Model: Qwen/Qwen3-8B
Question ID: test_0068
Response Length: 2784
==================================================
<think> Okay, let's tackle this question. The patient is a 57-year-old female with a history of alcoholism presenting with hematemesis (bright red blood) and melena (black, tarry stools). On exam, she has splenomegaly and a positive fluid wave, which suggests ascites. Her vital signs show tachycardia and hypotension, indicating possible hypovolemic shock from acute upper GI bleeding. The endoscopy found bleeding esophageal varices, which are common in cirrhosis, often due to chronic alcohol use. The management of acute variceal bleeding involves several steps: hemodynamic stabilization, vasoactive drugs like octreotide or terlipressin, endoscopic therapy (like band ligation), and initiation of beta-blockers for secondary prevention once the acute episode is controlled. The question asks which pharmacologic agent is indicated after the acute bleed is resolved. The options are Phentolamine, Prazosin, Nifedipine, and Nadolol. Looking at the documents, several mention beta-blockers (non-selective beta-blockers like propranolol, nadolol, or carvedilol) as part of secondary prevention to reduce portal pressure and prevent rebleeding. Document [0] states that after acute variceal hemorrhage, if the patient doesn't undergo TIPS, a nonselective beta-blocker should be started once vasoactive therapy is discontinued, unless contraindicated. Document [1] also mentions starting beta-blockers (or nitrates as an alternative) if no contraindications. Document [2] and [6] discuss NSBBs like carvedilol, propranolol, nadolol in reducing portal pressure and rebleeding risk. Document [11] specifically mentions nadolol used for prophylaxis in cirrhotic patients. Now, looking at the options: Nadolol (option D) is a non-selective beta-blocker, which fits the indication. The other options are alpha-blockers (Prazosin, Phentolamine) or a calcium channel blocker (Nifedipine). These are not mentioned in the context of post-acute variceal bleeding management. In fact, during acute bleeding, beta-blockers are avoided because they can lower blood pressure and reduce heart rate, which might worsen hemodynamic instability. But once the acute episode is controlled, they are started. So Nadolol (D) is the correct choice here. </think> {"step_by_step_thinking": "The patient presents with acute esophageal variceal bleeding, likely due to cirrhosis from alcoholism. After acute management with octreotide and endoscopic intervention, secondary prevention is needed. Nonselective beta-blockers (NSBBs) like nadolol are indicated to reduce portal pressure and prevent rebleeding, as per documents [0][1][2][6], and [11]. Other options (alpha-blockers, calcium channel blockers) are not indicated for this purpose. Nadolol (D) is a NSBB and fits the criteria.", "answer_choice": "D"}
==================================================
